NCT07097675 · NOT YET RECRUITING

The Change in Psychoemotional State of Individuals With Dementia Syndrome Applying Art Therapy

This trial is testing whether art therapy sessions can improve the emotional well-being of people already living with dementia — specifically measuring changes in anxiety, depression, and stress using a standardized art-based assessment scale called FEATS. It is a Phase NA study, meaning it is not a drug trial but a behavioral intervention study focused on whether a non-drug activity produces measurable emotional benefit.

You may qualify if

  • diagnosed with dementia;
  • MMSE ≥11 (mild to moderate cognitive impairment);
  • stable somatic condition;
  • vision and hearing sufficient to assess cognitive function and to administer interventions;
  • familiar with the purpose and conduct of the study;
  • signed an informed consent form.

You're excluded if

  • MMSE \< 11 points (severe cognitive impairment);
  • chronic, unstable somatic conditions;
  • Inability to comprehend the tasks;
  • Lack of knowledge of the Lithuanian language;
  • Refusal to take part in the study.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-07-31

View full record on ClinicalTrials.gov

All APOE4 clinical trials